about
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocy...
Read More
32.94
-0.46
(-1.38%)
111.1K
XNAS Volume
XNAS 11 Mar, 2026 1:14 PM (EDT)
Board Meeting
The latest board meeting for Vericel Corp took place on 10 Mar 2026, for the purpose of Leerink Partners 2026 Global Healthcare Conference
See details
Medium Financial Strength
Mid Valuation
Technically Bearish
Slowing Down Stock
These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest
View Similar
Embed DVM
Vericel Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..